FindTrial
Sign In

Smoking quit rates among pulmonary tuberculosis patients undergoing brief advice with or without nicotine replacement therapy

Effectiveness of Smoking Cessation among Pulmonary Tuberculosis Patients Undergoing Directly Observed Therapy Short Course- A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016457
Enrollment
300
Registered
2018-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Experimental Group: Behavioral therapy- Once a month for 3 months
nicotine chewing gums- 2 mg, 6 times a day for 3 months Control Intervention1: Brief Advice and Non- Nicotine Replacement Therapy Group: Brief Advice along with a non nicotine replacement therapy (pla
sugar-free mint flavoured chewing gums, 6 times a day for 3 months (Placebo)

Sponsors

K S Hegde Medical Academy
Lead Sponsor
K S Hegde Medical Academy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pulmonary Tuberculosis patients registered for DOTS with a history of smoking tobacco.

Exclusion criteria

Exclusion criteria: Smokeless-only Tobacco Users Pregnant Women

Design outcomes

Primary

MeasureTime frame
Smoking Cessation among the participantsTimepoint: 6 months—

Secondary

MeasureTime frame
Reduction in smokingTimepoint: 1 month—

Countries

India

Contacts

Public ContactJagannath Purushothama

Nitte University, Mangaluru, India

jagannathp@nitte.edu.in9242753747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026